Overview of the 2008 Food and Drug Administration Advisory Committee on safety considerations in the development of ultrasound contrast agents

Circulation. 2009 Apr 14;119(14):1956-61. doi: 10.1161/CIRCULATIONAHA.108.831156.

Authors

Federico M Asch¹, Neil J Weissman

Affiliation

¹ Washington Hospital Center, MedStar Research Institute, Washington, DC 20010, USA.

PMID: 19364988
DOI: 10.1161/CIRCULATIONAHA.108.831156

No abstract available

MeSH terms

Contrast Media / standards*
Duty to Warn
Echocardiography / standards*
Heart Diseases / diagnostic imaging
Humans
Product Surveillance, Postmarketing / standards
Safety / standards*
United States
United States Food and Drug Administration*

Substances

Contrast Media